🔎 Trials Near Me

Hjem › Makuladegeneration › Florida

Makuladegeneration kliniske forsøg i Florida

14 studier for Makuladegeneration søger deltagere på steder i Florida.

Byer i Florida

Officiel studietekst (engelsk)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Florida Eye Clinic (Site 130), Altamonte Springs
  • Retina Group of Florida (Site 070), Fort Lauderdale
  • Vitreo Retinal Associates, Gainesville
  • og 10 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Retina Group of Florida, Fort Lauderdale
  • VitreoRetinal Associates, PA, Gainesville
  • Retina Specialty Institute, Pensacola
  • og 1 flere
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Advanced Retina Institute-Ophthalmology, Bonita Springs
  • Advanced Research, Coral Springs
  • Retina Group of Florida, Fort Lauderdale
  • og 11 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

  • Advanced Retina Institute, Bonita Springs
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07811726

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Florida Retina Institute, Orlando
  • Retina Specialty Institute, Pensacola
  • Retina Group of Florida, Sarasota
  • og 1 flere
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • University of Florida Health - UF Health Jacksonville, Jacksonville
  • University of Miami Health System - Bascom Palmer Eye Institute, Miami
RekruttererObservationsstudie
Alder 6 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Retina Group of Florida, Fort Lauderdale
  • Vitreo Retinal Associates, Gainesville
  • Florida Eye Associates, Melbourne
  • og 2 flere
RekruttererFase 1/2
Alder 50 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Retina Group of Florida, Fort Myers
  • Florida Retina Institute, Orlando
  • Retina Group of Florida (Site 065), Sarasota
  • og 1 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

  • Adverum site 124, Deerfield Beach
  • Adverum site 176, Fort Lauderdale
  • Adverum site 168, Jacksonville
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07630649

Stem Cell Ophthalmology Treatment Study II

  • MD Stem Cells, Coral Springs
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT03011541

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • ClearVista Clinical Research, Hudson
  • Florida Retina Institute, Orlando
  • Retina Specialty Institute, Pensacola
  • og 3 flere
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT07064759

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:006, Deerfield Beach
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 7. feb. 2025 · NCT06132035

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Sarasota Retina Institute, Sarasota
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.